Moderna
American biotechnology company / From Wikipedia, the free encyclopedia
Moderna is an American biotechnology company based in Cambridge, Massachusetts. They focus on drug discovery and development, and vaccine technologies based on messenger RNA.[1]
As of November 2020, Moderna was valued at $35 billion, and while none of its drugs had been approved, its COVID-19 vaccine candidate was close to being authorized for mass use.[2]
In 2023 it is to build a centre in Harwell, Oxfordshire, to produce vaccines for Covid, flu and respiratory syncytial virus.[3]